TrialAntimicrobial agents and chemotherapy2012

Safety and pharmacokinetics of the anti-orthopoxvirus compound ST-246 following a single daily oral dose for 14 days in human volunteers.

Jarasvech Chinsangaram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.